To address new opportunities in the healthcare sector emerging from the increasing use of digital technologies, specifically telemedicine and mobile devices (mHealth), and to evaluate the impact of information and communication technology on health outcomes.


  • Establish a forum to address the opportunities and challenges emerging in the field of digital health
  • Understand the role of health economics and outcomes research (HEOR) in the value assessment of digital health solutions
  • Investigate the ways in which the validity and reliability of digital health technologies can be evaluated
  • Promote the effective use of digital technologies to improve patient outcomes and efficiency of healthcare systems


The term "digital health" is extremely broad and can include electronic medical records, electronic health records, telemedicine, mobile health (mHealth), and wireless health, amongst others. Utilization of digital health technologies provides opportunities to increase the quality of care, accuracy of healthcare analytics, and ensure greater safety owing to the patient follow-up. However, digital health represents a field fraught with challenges within the healthcare market. Not only are there numerous and different ways to classify and define “digital health” and related subtopics, there is also a lack of methodological approaches available to assess the value of digital health solutions.  The usefulness along with the quality and reliability of health information gathered via digital health (eg mobile apps) must be addressed before one can feel confident of the reliability of digital health solutions and subsequent use by patients and researchers for assessing the value of healthcare interventions.

Posters and Presentations

  1. ISPOR 2024: An Evidence Analysis Framework for Patient-Facing Digital Health Technology Assessment
  2. ISPOR Europe 2023: An Evidence Analysis Framework for Digital Health
  3. ISPOR Europe 2022: Quo Vadis? Evolving the ISPOR Digital Health SIG for 2023 and Beyond
  4. Virtual ISPOR Europe 2021: Do ICERs Support the Digital Revolution?
  5. HTAi 2021 Virtual Annual Meeting: Poster: Piloting a Comprehensive Search for Ehealth Definitions in the Grey Literature: Preliminary Results from a Systematic Scoping Review
  6. HTAi 2021 Virtual Annual Meeting: Poster: Categorization of Digital Health Definitions for Outcomes Research Purposes - Results of a Systematic Scoping Literature Review
  7. Virtual ISPOR 2021: Quo vadis? Results of the Systematic Scoping Review for Digital Health Terms in the Literature
  8. Virtual ISPOR 2021: Poster: How Do We Agree on A Definition for Digital Health? - Results of a Systematic Scoping Literature Review
  9. ISPOR Midwest Chapter, February 2021: Digital Health and Applications in Health Outcomes Research



Brian Seal, MBA, RPh, BS, PhD

Germantown, MD, United States

Past Chair

Vlad Zah, PhD, BSc

Health Economist, ZRx Outcomes Research, Inc
Mississauga, ON, Canada


Anita Burrell, MBA, BA, MA

Founder, Anita Burrell Consulting LLC
Flemington, NJ, United States

Operational Lead

Lisa Weiss

Senior Director, MDIC
NEW YORK, NY, United States

Working Groups

Member Engagement

These activities allow for a variety of members to participate and facilitates disseminating content in Webinars, Journal Clubs, Conference Sessions, etc.

Artem Boltyenkov, MSc, MBA, PhD, BSc

Head, global HEOR, Siemens Medical Solutions USA
Lexington, SC, United States

Jagadeswara Rao Earla, MBA, PharmD, PhD

Associate Director, Outcomes Research, Merck & Co. Inc
Rahway, NJ, United States

Anne Kilburg, MSc

Founder & Owner, KilburgDialogue
Basel, BS, Switzerland

Key Project

In development

    Background and Objectives for Key Project

    More information coming soon!

    Questions or ideas? Please send an email to digitalhealthsig@ISPOR.org

    Your browser is out-of-date

    ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now